Frontiers in Genomics: Sriram Chandrasekaran
Drug discovery and repurposing using mechanistic AI
Auditorio "Dr. Guillermo Soberón" del CCG
Centro de Ciencias Genómicas UNAM Morelos, Cuernavaca, Morelos, Mexico
Sriram Chandrasekaran, Assistant Professor, Biomedical Engineering, University of Michigan, Ann Arbor Seminar abstract: By 2050, we may lose 10 million people a year to drug-resistant infections. Unfortunately, the pace of drug discovery has not kept up with the rapid emergence of these pathogens. Drug combinations have great potential to reduce the spread of drug-resistant bacteria. […]
Frontiers in Genomics: Judy Lieberman
How Tumors Avoid Immune Recognition and Elimination
Auditorio "Dr. Francisco Bolivar" del IBt
Instituto de Biotecnología UNAM Morelos, Cuernavaca, Morelos, Mexico
Judy Lieberman, Chair in Cellular and Molecular Medicine, Program in Cellular and Molecular Medicine, Boston Children's Hospital; Professor of Pediatrics, Harvard Medical School https://www.mcb.harvard.edu/directory/judy-lieberman/ https://www.dfhcc.harvard.edu/insider/member-detail/member/judy-lieberman-md-phd/ Frontiers in Genomics
Frontiers in Genomics: William Harcombe
The metabolic basis of eco-evolutionary dynamics in microbial systems
Transmisión en vivo
William Harcombe, University of Minnesota Predicting eco-evolutionary dynamics is vital to our ability to understand and manage critical microbial communities. Using computational models and experimental systems we have found that metabolic mechanisms provide a basis for quantitatively predicting the dynamics of microbial systems. We have found that when microbes cross-feed, obtaining metabolites from one another, […]
Frontiers in Genomics: Chad Bousman
Precision Prescribing of Psychiatric Medications: Are we there yet?
Auditorio "Dr. Francisco Bolivar" del IBt
Instituto de Biotecnología UNAM Morelos, Cuernavaca, Morelos, Mexico
Summary: In this seminar I will provide an overview of the evidence for using pharmacogenomics to guide prescribing, present clinical situations where pharmacogenomics could be useful, and describe key considerations for using pharmacogenomics in practice. Chad Bousman, Associate Professor, Departments of Medical Genetics, Psychiatry, Physiology & Pharmacology, and Community Health Sciences, University of Calgary https://profiles.ucalgary.ca/chad-bousman Frontiers in […]
Frontiers in Genomics: Wolfgang Busch
Decoding Root Growth to Mitigate Climate Change
Auditorio "Dr. Francisco Bolivar" del IBt
Instituto de Biotecnología UNAM Morelos, Cuernavaca, Morelos, Mexico
Decoding Root Growth to Mitigate Climate Change Climate change will soon profoundly and negatively affect the vast majority of our planet’s biota, including most human beings. Despite the importance and urgency of addressing this problem, we still lack technologies to globally address the root cause of climate change – increased levels of CO2 in the […]
Frontiers in Genomics: Raquel Cuevas-Díaz Durán
Non-coding RNAs and DNA regions are important regulators of gene expression in cells of the central nervous system
Transmisión en vivo
Raquel Cuevas-Díaz Durán, School of Medicine and Health Sciences, ITESM https://research.tec.mx/vivo-tec/display/PID_66289 Resumen de la ponencia The nervous system of multicellular organisms comprises highly specialized cells which perform distinct physiological functions. Even though they possess nearly identical genomic DNA, their spatio-temporal heterogeneity is achieved through epigenetic mechanisms, for example DNA methylation, histone post-transcriptional modifications, chromatin remodeling, […]
Frontiers in Genomics: James Galagan
A neural network for quantitative biophysical transcription factor binding site design
Auditorio "Dr. Guillermo Soberón" del CCG
Centro de Ciencias Genómicas UNAM Morelos, Cuernavaca, Morelos, Mexico
Resumen de la ponencia High throughput genomic methods, such as ChIP-Seq, have greatly expanded our knowledge of transcription factor (TF) binding to DNA. A frequent observation is the presence of binding sites for individual TFs that span a wide range of apparent affinities. A quantitative biophysical understanding of the basis of TF binding strength is […]
Frontiers in Genomics: Tony Hunter
A journey from tyrosine to histidine phosphorylation: uncovering new cancer mechanisms
Auditorio "Dr. Guillermo Soberón" del CCG
Centro de Ciencias Genómicas UNAM Morelos, Cuernavaca, Morelos, Mexico
Tony Hunter, American Cancer Society Professor, Molecular and Cell Biology Laboratory, Renato Dulbecco Chair, Salk Institute Resumen de la ponencia I will discuss our recent studies on protein histidine phosphorylation and its function as a reversible posttranslational modification. I will describe how we developed monoclonal antibodies specific for the 1-pHis and 3-pHis isoforms, and have […]
Frontiers in Genomics: Juan Francisco Jiménez Bremont
Descifrando la función de genes de respuesta a estrés abiótico en plantas
Auditorio "Dr. Guillermo Soberón" del CCG
Centro de Ciencias Genómicas UNAM Morelos, Cuernavaca, Morelos, Mexico
Juan Francisco Jiménez Bremont, Profesor-Investigador Titular C (SNI 3), Division de Biología Molecular, Instituto Potosino de Investigación Científica y Tecnológica (IPICyT) Resumen de la ponencia Nuestro grupo de investigación se ha enfocado en la caracterización molecular y funcional de genes involucrados en la respuesta al estrés de plantas. Inicialmente mediante bibliotecas cDNA construidas en frijol, […]
Frontiers in Genomics: Alejandro Sánchez Alvarado
Dissecting the biological complexity of animal regeneration
Auditorio "Dr. Francisco Bolivar" del IBt
Instituto de Biotecnología UNAM Morelos, Cuernavaca, Morelos, Mexico
Alejandro Sánchez Alvarado, Stowers Institute for Medical Research https://www.stowers.org/labs/sanchez-alvarado-lab https://youtube.com/live/8YaefxZtNxI?feature=share Frontiers in Genomics